Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)

Authors

  • Alejandra Tomás-Velázquez Department of Dermatology, University Clinic of Navarra / Fundación Piel Sana, ES-28008 Madrid, Spain
  • Onofre Sanmartin-Jiménez
  • Joan R. Garcés
  • Manuel A. Rodríguez-Prieto
  • Verónica Ruiz-Salas
  • Esther de Eusebio-Murillo
  • Román Miñano-Medrano
  • Begoña Escutia-Muñoz
  • Ángeles Flórez-Menéndez
  • Juan L. Artola-Igarza
  • Alberto Alfaro-Rubio
  • Pilar Gil
  • Yolanda Delgado-Jiménez
  • Julia M. Sanchez-Schmidt
  • Irati Allende-Markixana
  • María L. Alonso-Pacheco
  • Beatriz García-Bracamonte
  • Pablo de la Cueva-Dobao
  • Raquel Navarro-Tejedor
  • Cristina Ciudad-Blanco
  • Lucía Carnero-González
  • Hugo Vázquez-Veiga
  • Natividad Cano-Martínez
  • Eva Vilarrasa-Rull
  • Pedro Sanchez-Sambucety
  • José L. López-Estebaranz
  • Rafael Botella-Estrada
  • Beatriz Gonzalez-Sixto
  • Antonio Martorell-Calatayud
  • Victoriano Morales-Gordillo
  • Agustí Toll-Abelló
  • Izascun Ocerin-Guerra
  • Matías Mayor-Arenal
  • Ricardo Suárez-Fernández
  • Laura Sainz-Gaspar
  • Miguel A. Descalzo
  • Ignacio García-Doval
  • Pedro Redondo

DOI:

https://doi.org/10.2340/actadv.v101.544

Keywords:

basal cell carcinoma, squamous cell carcinoma, Mohs surgery, recurrence, risk factors

Abstract

Randomized studies to assess the efficacy of Mohs micrographic surgery in basal cell and squamous cell carcinomas are limited by methodological and ethical issues and a lack of long follow-up periods. This study presents the “real-life” results of a nationwide 7-years cohort on basal cell carcinoma and squamous cell carcinoma treated with Mohs micrographic surgery. A prospective cohort was conducted in 22 Spanish centres (from July 2013 to February 2020) and a multivariate analysis, including characteristics of patients, tumours, surgeries and follow-up, was performed. A total of 4,402 patients followed up for 12,111 patient-years for basal cell carcinoma, and 371 patients with 915 patient-years of follow-up for squamous cell carcinoma were recruited. Risk factors for recurrence included age, non-primary tumours and more stages or unfinished surgeries for both tumours, and immunosuppression for squamous cell carcinoma. Incidence rates of recurrence were 1.3 per 100 person-years for basal cell carcinoma (95% confidence interval 1.1–1.5) and 4.5 for squamous cell carcinoma (95% confidence interval 3.3–6.1), being constant over time (0–5 years). In conclusion, follow-up strategies should be equally intense for at least the first 5 years, with special attention paid to squamous cell carcinoma (especially in immunosuppressed patients), elderly patients, non-primary tumours, and those procedures requiring more stages, or unfinished surgeries.

Downloads

Download data is not yet available.

References

Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069-1080.

https://doi.org/10.1111/j.1365-2133.2012.10830.x DOI: https://doi.org/10.1111/j.1365-2133.2012.10830.x

Tejera-Vaquerizo A, Descalzo-Gallego MA, Otero-Rivas MM, Posada-Garcia C, Rodriguez-Pazos L, Pastushenko I, et al. Skin cancer incidence and mortality in spain: a systematic review and meta-analysis. Actas Dermosifiliogr 2016; 107: 318-328. DOI: https://doi.org/10.1016/j.adengl.2016.02.015

https://doi.org/10.1016/j.ad.2015.12.008 DOI: https://doi.org/10.1016/j.ad.2015.12.008

Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ. Basal cell carcinoma: what's new under the sun. Photochem Photobiol 2010; 86: 481-491.

https://doi.org/10.1111/j.1751-1097.2010.00735.x DOI: https://doi.org/10.1111/j.1751-1097.2010.00735.x

Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 2019; 118: 10-34.

https://doi.org/10.1016/j.ejca.2019.06.003 DOI: https://doi.org/10.1016/j.ejca.2019.06.003

Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol 2018; 78: 237-247.

https://doi.org/10.1016/j.jaad.2017.08.059 DOI: https://doi.org/10.1016/j.jaad.2017.08.059

Shriner DL, McCoy DK, Goldberg DJ, Wagner RF, Jr. Mohs micrographic surgery. J Am Acad Dermatol 1998; 39: 79-97.

https://doi.org/10.1016/S0190-9622(98)70405-0 DOI: https://doi.org/10.1016/S0190-9622(98)70405-0

Ad Hoc Task F, Connolly SM, Baker DR, Coldiron BM, Fazio MJ, Storrs PA, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol 2012; 67: 531-550.

https://doi.org/10.1016/j.jaad.2012.06.009 DOI: https://doi.org/10.1016/j.jaad.2012.06.009

Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005; 53: 253-260.

https://doi.org/10.1016/j.jaad.2005.02.059 DOI: https://doi.org/10.1016/j.jaad.2005.02.059

Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005; 53: 445-451.

https://doi.org/10.1016/j.jaad.2005.04.083 DOI: https://doi.org/10.1016/j.jaad.2005.04.083

Rowe DE, Carroll RJ, Day CL, Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26: 976-990.

https://doi.org/10.1016/0190-9622(92)70144-5 DOI: https://doi.org/10.1016/0190-9622(92)70144-5

Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008; 9: 1149-1156.

https://doi.org/10.1016/S1470-2045(08)70260-2 DOI: https://doi.org/10.1016/S1470-2045(08)70260-2

Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004; 364: 1766-1772.

https://doi.org/10.1016/S0140-6736(04)17399-6 DOI: https://doi.org/10.1016/S0140-6736(04)17399-6

Van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, et al. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. Eur J Cancer 2014; 50: 3011-3020.

https://doi.org/10.1016/j.ejca.2014.08.018 DOI: https://doi.org/10.1016/j.ejca.2014.08.018

Muller FM, Dawe RS, Moseley H, Fleming CJ. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome. Dermatol Surg 2009; 35: 1349-1354.

https://doi.org/10.1111/j.1524-4725.2009.01240.x DOI: https://doi.org/10.1111/j.1524-4725.2009.01240.x

Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005; 53: 452-457.

https://doi.org/10.1016/j.jaad.2005.04.087 DOI: https://doi.org/10.1016/j.jaad.2005.04.087

Tschetter AJ, Campoli MR, Zitelli JA, Brodland DG. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: a 5-year, multicenter, prospective cohort study. J Am Acad Dermatol 2020; 82: 139-148.

https://doi.org/10.1016/j.jaad.2019.06.1303 DOI: https://doi.org/10.1016/j.jaad.2019.06.1303

Drucker AM, Adam GP, Rofeberg V, Gazula A, Smith B, Moustafa F, et al. Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis. Ann Intern Med 2018; 169: 456-466.

https://doi.org/10.7326/M18-0678 DOI: https://doi.org/10.7326/M18-0678

Motley R, Arron S. Mohs micrographic surgery for cutaneous squamous cell carcinoma. Br J Dermatol 2019; 181: 233-234.

https://doi.org/10.1111/bjd.18161 DOI: https://doi.org/10.1111/bjd.18161

Delgado Jimenez Y, Camarero-Mulas C, Sanmartin-Jimenez O, Garces JR, Rodriguez-Prieto MA, Alonso-Alonso T, et al. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma. Int J Dermatol 2018; 57: 1375-1381.

https://doi.org/10.1111/ijd.14223 DOI: https://doi.org/10.1111/ijd.14223

Ruiz-Salas V, Garces JR, Minano Medrano R, Alonso-Alonso T, Rodriguez-Prieto MA, Lopez-Estebaranz JL, et al. Description of patients undergoing Mohs surgery in Spain: initial report on data from the Spanish Registry of Mohs surgery (REGESMOHS). Actas Dermosifiliogr 2015; 106: 562-568. DOI: https://doi.org/10.1016/j.adengl.2015.06.011

https://doi.org/10.1016/j.ad.2015.04.002 DOI: https://doi.org/10.1016/j.ad.2015.04.002

Alonso-Alonso T, Redondo-Bellon P, Sanmartin-Jimenez O, de Eusebio-Murillo E, Garcia-Doval I, Rodriguez-Prieto MA. Census of centers that perform Mohs' micrographic surgery in Spain and description of their activity: a feasibility study for the Mohs' Micrographic Surgery Registry of the Foundation of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr 2015; 106: 764-766. DOI: https://doi.org/10.1016/j.adengl.2015.09.016

https://doi.org/10.1016/j.ad.2015.02.014 DOI: https://doi.org/10.1016/j.ad.2015.02.014

Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face - results of a retrospective study and review of the literature. Br J Dermatol 2004; 151: 141-147.

https://doi.org/10.1111/j.1365-2133.2004.06047.x DOI: https://doi.org/10.1111/j.1365-2133.2004.06047.x

Dzubow LM, Rigel DS, Robins P. Risk factors for local recurrence of primary cutaneous squamous cell carcinomas. Treatment by microscopically controlled excision. Arch Dermatol 1982; 118: 900-902. DOI: https://doi.org/10.1001/archderm.118.11.900

https://doi.org/10.1001/archderm.1982.01650230028021 DOI: https://doi.org/10.1001/archderm.1982.01650230028021

Marrazzo G, Zitelli JA, Brodland D. Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone. J Am Acad Dermatol 2019; 80: 633-638.

https://doi.org/10.1016/j.jaad.2018.09.015 DOI: https://doi.org/10.1016/j.jaad.2018.09.015

Eigentler TK, Leiter U, Hafner HM, Garbe C, Rocken M, Breuninger H. Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study. J Invest Dermatol 2017; 137: 2309-2315.

https://doi.org/10.1016/j.jid.2017.06.025 DOI: https://doi.org/10.1016/j.jid.2017.06.025

Julian CG, Bowers PW. A prospective study of Mohs' micrographic surgery in two English centres. Br J Dermatol 1997; 136: 515-518.

https://doi.org/10.1111/j.1365-2133.1997.tb02133.x DOI: https://doi.org/10.1111/j.1365-2133.1997.tb02133.x

Mohs FE. Chemosurgery for the microscopically controlled excision of cutaneous cancer. Head Neck Surg 1978; 1: 150-166.

https://doi.org/10.1002/hed.2890010209 DOI: https://doi.org/10.1002/hed.2890010209

Mohs FE. Chemosurgery: microscopically controlled surgery for skin cancer - past, present and future. J Dermatol Surg Oncol 1978; 4: 41-54.

https://doi.org/10.1111/j.1524-4725.1978.tb00379.x DOI: https://doi.org/10.1111/j.1524-4725.1978.tb00379.x

Robins P. Chemosurgery: my 15 years of experience. J Dermatol Surg Oncol 1981; 7: 779-789.

https://doi.org/10.1111/j.1524-4725.1981.tb00166.x DOI: https://doi.org/10.1111/j.1524-4725.1981.tb00166.x

Veronese F, Farinelli P, Zavattaro E, Zuccoli R, Bonvini D, Leigheb G, et al. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery. J Eur Acad Dermatol Venereol 2012; 26: 838-843.

https://doi.org/10.1111/j.1468-3083.2011.04165.x DOI: https://doi.org/10.1111/j.1468-3083.2011.04165.x

Weesie F, Naus NC, Vasilic D, Hollestein LM, van den Bos RR, Wakkee M. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study. Br J Dermatol 2019; 180: 1176-1182.

https://doi.org/10.1111/bjd.17516 DOI: https://doi.org/10.1111/bjd.17516

Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol 2005; 53: 261-266.

https://doi.org/10.1016/j.jaad.2005.03.048 DOI: https://doi.org/10.1016/j.jaad.2005.03.048

Holmkvist KA, Roenigk RK. Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: outcome at 5 years. J Am Acad Dermatol 1998; 38: 960-966.

https://doi.org/10.1016/S0190-9622(98)70160-4 DOI: https://doi.org/10.1016/S0190-9622(98)70160-4

Pugliano-Mauro M, Goldman G. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2010; 36: 1544-1553.

https://doi.org/10.1111/j.1524-4725.2010.01576.x DOI: https://doi.org/10.1111/j.1524-4725.2010.01576.x

Downloads

Published

2021-11-24

How to Cite

Tomás-Velázquez, A., Sanmartin-Jiménez, O., Garcés, J. R., Rodríguez-Prieto, M. A., Ruiz-Salas, V., de Eusebio-Murillo, E., Miñano-Medrano, R., Escutia-Muñoz, B., Flórez-Menéndez, Ángeles, Artola-Igarza, J. L., Alfaro-Rubio, A., Gil, P., Delgado-Jiménez, Y., Sanchez-Schmidt, J. M., Allende-Markixana, I., Alonso-Pacheco, M. L., García-Bracamonte, B., de la Cueva-Dobao, P., Navarro-Tejedor, R., Ciudad-Blanco, C., Carnero-González, L., Vázquez-Veiga, H., Cano-Martínez, N., Vilarrasa-Rull, E., Sanchez-Sambucety, P., López-Estebaranz, J. L., Botella-Estrada, R., Gonzalez-Sixto, B., Martorell-Calatayud, A., Morales-Gordillo, V., Toll-Abelló, A., Ocerin-Guerra, I., Mayor-Arenal, M., Suárez-Fernández, R., Sainz-Gaspar, L., Descalzo, M. A., García-Doval, I., & Redondo, P. (2021). Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery). Acta Dermato-Venereologica, 101(11), adv00602. https://doi.org/10.2340/actadv.v101.544